Different prognostic roles of tumor suppressor geneBAP1in cancer: A systematic review with meta-analysis

Extranodal extension is an important prognostic parameter for both colonic and rectal cancer

(2016) C. Luchini et al.   ANNALS OF ONCOLOGY

New genomic landscapes and therapeutic targets for biliary tract cancers

(2016) Matteo Fassan   Frontiers in Bioscience-Landmark

Clear Cell Renal Cell Carcinoma Subtypes Identified by BAP1 and PBRM1 Expression

(2016) Richard W. Joseph et al.   JOURNAL OF UROLOGY

Loss of BAP1 Expression Occurs Frequently in Intrahepatic Cholangiocarcinoma

(2016) Juliana Andrici et al.   MEDICINE

Loss of expression of BAP1 is very rare in non-small cell lung carcinoma

(2016) Juliana Andrici et al.   PATHOLOGY

Prognostic implications of extranodal extension in node-positive squamous cell carcinoma of the vulva: A systematic review and meta-analysis

(2016) Claudio Luchini et al.   SURGICAL ONCOLOGY-OXFORD

Prognostic impact and implications of extracapsular lymph node involvement in colorectal cancer: a systematic review with meta-analysis

(2015) N. Veronese et al.   ANNALS OF ONCOLOGY

The BAP1/ASXL2 Histone H2A Deubiquitinase Complex Regulates Cell Proliferation and Is Disrupted in Cancer

(2015) Salima Daou et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

BAP1 Has a Survival Role in Cutaneous Melanoma

(2015) Raj Kumar et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Prognostic impact of extra-nodal extension in thyroid cancer: A meta-analysis

(2015) Nicola Veronese et al.   JOURNAL OF SURGICAL ONCOLOGY

BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations

(2015) Marta Cigognetti et al.   MODERN PATHOLOGY

Loss of expression of BAP1 predicts longer survival in mesothelioma

(2015) Mahtab Farzin et al.   PATHOLOGY

Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups

(2015) Michele Simbolo et al.   Oncotarget

Lack of BAP1 protein expression in uveal melanoma is associated with increased metastatic risk and has utility in routine prognostic testing

(2014) H Kalirai et al.   BRITISH JOURNAL OF CANCER

Prognostic parameters in uveal melanoma and their association with BAP1 expression

(2014) T Huibertus van Essen et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Germline Mutation of Bap1 Accelerates Development of Asbestos-Induced Malignant Mesothelioma

(2014) J. Xu et al.   CANCER RESEARCH

Germline Mutations in BAP1 Impair Its Function in DNA Double-Strand Break Repair

(2014) I. H. Ismail et al.   CANCER RESEARCH

Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival

(2014) Francine Baumann et al.   CARCINOGENESIS

Next-Generation Histopathologic Diagnosis: A Lesson From a Hepatic Carcinosarcoma

(2014) Claudio Luchini et al.   JOURNAL OF CLINICAL ONCOLOGY

Clinical significance of immunohistochemistry for detection of BAP1 mutations in uveal melanoma

(2014) Anna E Koopmans et al.   MODERN PATHOLOGY

Mutation Profiling in Cholangiocarcinoma: Prognostic and Therapeutic Implications

(2014) Chaitanya R. Churi et al.   PLoS One

Loss of BAP1 protein expression is an independent marker of poor prognosis in patients with low-risk clear cell renal cell carcinoma

(2013) Richard W. Joseph et al.   CANCER

Clinical and pathological impact ofVHL, PBRM1, BAP1, SETD2, KDM6A, andJARID1cin clear cell renal cell carcinoma

(2013) Lucy Gossage et al.   GENES CHROMOSOMES & CANCER

Clinical Characteristics of Patients with Malignant Pleural Mesothelioma Harboring Somatic BAP1 Mutations

(2013) Marjorie G. Zauderer et al.   Journal of Thoracic Oncology

BAP1 Immunohistochemistry Predicts Outcomes in a Multi-Institutional Cohort with Clear Cell Renal Cell Carcinoma

(2013) Payal Kapur et al.   JOURNAL OF UROLOGY

Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation

(2013) Payal Kapur et al.   LANCET ONCOLOGY

Prognostic significance of BRCA1-associated protein 1 in colorectal cancer

(2013) Jianjun Tang et al.   MEDICAL ONCOLOGY

Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas

(2013) Yuchen Jiao et al.   NATURE GENETICS

BAP1 protein loss by immunohistochemistry: A potentially useful tool for prognostic prediction in patients with uveal melanoma

(2013) Akeesha A. Shah et al.   PATHOLOGY

BAP1 Protein is a Progression Factor in Malignant Pleural Mesothelioma

(2013) Lisa Arzt et al.   PATHOLOGY & ONCOLOGY RESEARCH

Somatic mutation of a tumor suppressor gene BAP1 is rare in breast, prostate, gastric and colorectal cancers

(2012) Eun Mi Je et al.   APMIS

Clinical and Pathologic Impact of Select Chromatin-modulating Tumor Suppressors in Clear Cell Renal Cell Carcinoma

(2012) A. Ari Hakimi et al.   EUROPEAN UROLOGY

An Emerging Model for BAP1’s Role in Regulating Cell Cycle Progression

(2011) Ziad M. Eletr et al.   CELL BIOCHEMISTRY AND BIOPHYSICS

The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma

(2011) Matthew Bott et al.   NATURE GENETICS

Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas

(2010) J. W. Harbour et al.   SCIENCE

BRCA1-Associated Protein-1 Is a Tumor Suppressor that Requires Deubiquitinating Activity and Nuclear Localization

(2008) K. H. Ventii et al.   CANCER RESEARCH

BRCA1-Associated Protein 1 Interferes with BRCA1/BARD1 RING Heterodimer Activity

(2008) H. Nishikawa et al.   CANCER RESEARCH